Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Indonesian Journal of Urology
Hemant Kumar Goel
Unknown Affiliation
Health Professions Medicine & Pharmacology Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
COMPARATIVE STUDY OF CLINICAL SAFETY OUTCOME OF NEOADJUVANT INTRAVESICAL MITOMYCIN-C THERAPY IMMEDIATELY BEFORE TRANSURETHRAL RESECTION OF BLADDER TUMOR VS PERIOPERATIVE INTRAVESICAL MITOMYCIN-C IN PATIENTS WITH NONMUSCLE-INVASIVE BLADDER CANCER Dhirendra Singh; Umesh Sharma; Hemant Kumar Goel; Abhishek Saini
Indonesian Journal of Urology Vol 33 No 1 (2026)
Publisher : Indonesian Urological Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32421/juri.v33i1.1125

Abstract

Objective: This study aims to compare the outcome and complications of adjuvant vs neoadjuvant IMMC (intravesical mitomycin C) for non-muscle-invasive bladder cancer (NMIBC). Material & Methods: This prospective randomized observational study was conducted from June 2023 to December 2024. Sixty-two patients with clinico-radiological evidence of bladder growth were randomized into two arms: Neoadjuvant IMMC and Perioperative IMMC. Results: Immediate complications were more frequent in Group B, with significantly higher dysuria, suprapubic pain (74.2% vs 32.3%), and febrile UTIs (29% vs 3.2%). Haematuria was also more common in Group B (58.1%). Early complications showed similar trends: dysuria (51.6% vs 19.4%), haematuria (45.2% vs 19.4%), and bladder changes (23.3% vs 0%) were more prevalent in Group B. Allergic reactions were slightly lower in Group B (6.5%) than in Group A (9.7%). Conclusion: Pre-operative MMC instillation was more effective in reducing recurrence and improving resection ease, with fewer complications. Perioperative MMC was associated with increased inflammation and adverse events. Pre-TURBT MMC is recommended for improved clinical outcomes, while peri-operative MMC may be considered for select low-risk patients. Keywords: Complication, IMMC, bladder cancer.
Co-Authors Abhishek Saini Dhirendra Singh Umesh Sharma